Phosphatidylethanolamine
|
Basic information |
| Metabolite name | Phosphatidylethanolamine |
 | HMDB0060501 |
 |
C00350 |
 |
17754131 |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | Phosphatidylethanolamine |
| HMDB0060501 |
|
C00350 |
|
17754131 |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between Phosphatidylethanolamine and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1077 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M673 | Type1 | CUS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M673 | Type2 | CUS + fluoxetine group vs. CUS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M673 | Type2 | CUS + rTMS group vs. CUS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M823 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |